63 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
Compensation Program Looking Forward: 2024 Compensation Program* Base Salary Annual Incentive (Paid in cash) Allows us to attract and retain talent … on sustainability and social impact Important component of attracting specialized talent Rewards creation of incremental shareholder value Provides a mix of short
DFAN14A
EX-99.1
KRTX
Karuna Therapeutics Inc
22 Dec 23
Additional proxy materials by non-management
4:21pm
-positioned to reach those living with schizophrenia and Alzheimer’s disease psychosis. This announcement is a testament to the Karuna team’s talent, hard
8-K
EX-99.1
jq5a4k9 usx
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
EX-99.2
609jak43kiddu
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
94r8z7r84adonbkw5n93
10 Oct 23
Additional proxy materials by non-management
6:48am
8-K
EX-99.1
fb5jkek8y2
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
DEFA14A
z9hrdq fvptvnd
26 Apr 23
Additional proxy soliciting materials
4:38pm
8-K
EX-99.1
uyjzb295v
26 Apr 23
Bristol Myers Squibb Announces Leadership Transition Plan
4:35pm
DEFA14A
w0osvc
10 Apr 23
Additional proxy soliciting materials
5:12pm
DEFA14A
1xd4nae4hkcv30sa ld
20 Apr 22
Additional proxy soliciting materials
4:30pm
8-K
EX-99.1
1q1lh qhdukt
16 Nov 21
Regulation FD Disclosure
9:20am
8-K
EX-99.1
4qnlrq
27 Oct 21
Bristol Myers Squibb Reports Third Quarter Financial Results for 2021
9:46am
S-8 POS
n0c gwv7h4gma
4 May 21
Registration of securities for employees (post-effective amendment)
4:55pm
DEFA14A
ngcm0lo6fvlaiyd98g30
19 Apr 21
Additional proxy soliciting materials
7:41am